Morgan Wong, DO
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 9 carriers
- Office
- 1
Offices
1 location · San Jose Gastroenterology, Inc. · 11 clinicians in this group
Hospitals listed: El Camino Health · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
34 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wong’s office at (408) 347-9001 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$78,644
Medicare paid this office $78,644 for 254 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 65 | $14,174 | $218 |
| New patient visit (45+ min) | 74 | $10,722 | $145 |
| Return visit (30+ min) | 56 | $8,278 | $115 |
| Pathology examination of tissue using a microscope, intermediate complexity | 71 | $6,144 | $40 |
| Short return visit (20+ min) | 46 | $4,487 | $79 |
See all 14 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 65 | $14,174 | $218 |
| New patient visit (45+ min) | 74 | $10,722 | $145 |
| Return visit (30+ min) | 56 | $8,278 | $115 |
| Pathology examination of tissue using a microscope, intermediate complexity | 71 | $6,144 | $40 |
| Short return visit (20+ min) | 46 | $4,487 | $79 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $4,192 | $72 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $2,586 | $144 |
| Incision of pancreatic outlet using a flexible endoscope | 12 | $2,339 | $195 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 11 | $2,256 | $205 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,853 | $154 |
| Special stained specimen slides to identify organisms including interpretation and report | 14 | $1,751 | $97 |
| Biopsy of large bowel using a flexible endoscope | 13 | $1,024 | $79 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 12 | $249 | $21 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 21 | $98 | $5 |
Procedures Medicare counted
| Colonoscopy | 109 | More than 82% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 109 | More than 78% of doctors who do this |
Who their Medicare patients are
254 Original Medicare patients in 2024. Average age 74 · Under 65 6% · 85 and older 13% · Women 57% · Also on Medicaid 55% · Health risk score 1.45. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 44% · Coronary heart disease 28% · Chronic kidney disease 22% · Heart failure 18% · Atrial fibrillation 17% · Cancer 15% · COPD 13% · Depression 12% · Dementia 10% · Stroke 7%.
The office billed $457,687, Medicare allowed $101,831 and paid $78,644; for 727 services of 52 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 254 | 727 | 74 | 1.45 | $457,687 | $78,644 |
| 2023 | 316 | 971 | 75 | 1.96 | $391,353 | $113,565 |
| 2022 | 249 | 623 | 73 | 1.98 | $244,787 | $70,678 |
| 2021 | 85 | 115 | 69 | 1.83 | $44,887 | $9,749 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 76 | $16,747 | $217 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 81 | $13,114 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $10,092 | $110 |
| New patient visit (45+ min) | 56 | $8,826 | $158 |
| Pathology examination of tissue using a microscope, intermediate complexity | 69 | $6,252 | $40 |
| Short return visit (20+ min) | 52 | $5,424 | $85 |
| Insertion of stent into pancreatic or bile duct using a flexible endoscope | 11 | $5,042 | $420 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $4,811 | $209 |
| Return visit (30+ min) | 32 | $4,540 | $123 |
| Incision of pancreatic outlet using a flexible endoscope | 25 | $4,342 | $167 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $3,548 | $161 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,375 | $153 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 42 | $3,125 | $73 |
| Biopsy of large bowel using a flexible endoscope | 21 | $1,832 | $87 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,755 | $92 |
| Special stained specimen slides to identify organisms including interpretation and report | 11 | $1,479 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,386 | $73 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 27 | $667 | $22 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 34 | $161 | $5 |
2022: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $13,476 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $7,329 | $90 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 24 | $5,088 | $212 |
| New patient visit (45+ min) | 27 | $3,939 | $146 |
| Return visit (30+ min) | 35 | $3,769 | $99 |
| Short return visit (20+ min) | 30 | $2,424 | $73 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $2,414 | $101 |
| New patient visit (30+ min) | 26 | $2,399 | $92 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,355 | $168 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,352 | $62 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,064 | $83 |
| Biopsy of large bowel using a flexible endoscope | 12 | $1,818 | $152 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,812 | $151 |
| Pathology examination of tissue using a microscope, intermediate complexity | 19 | $1,528 | $37 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 29 | $134 | $5 |
2021: 4 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,494 | $107 |
| Return visit (30+ min) | 12 | $944 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $676 | $56 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $58 | $4 |
Medicaid work
$897 in 2024
Medicaid paid $897 for 155 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| COLONOSCOPY W/LESION REMOVAL | 39 | $687 |
| Return visit (30+ min) | 25 | $171 |
| Upper gastrointestinal endoscopy with biopsy | 12 | $32 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 12 | $8 |
| TISSUE EXAM BY PATHOLOGIST | 54 | $0 |
| New patient visit (45+ min) | 13 | $0 |
| 2024 | 155 | 6 | 17 | $897 |
| 2023 | 376 | 6 | 30 | $7,753 |
| 2022 | 223 | 4 | 30 | $4,259 |
| 2021 | 15 | 1 | 15 | $776 |
See the largest Medicaid services in earlier years
2023
| 1ST HOSP IP/OBS HIGH 75 | 116 | $3,609 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 128 | $2,634 |
| COLONOSCOPY W/LESION REMOVAL | 43 | $1,013 |
| TISSUE EXAM BY PATHOLOGIST | 46 | $396 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 30 | $101 |
| Short return visit (20+ min) | 13 | $0 |
2022
| 1ST HOSP IP/OBS HIGH 75 | 100 | $2,540 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 88 | $1,402 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 22 | $264 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 13 | $53 |
2021
| Return visit (30+ min) | 15 | $776 |
Drugs they prescribed that Part D paid
$85,108
Pharmacies billed $85,108 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
438 generic and 112 brand-name prescriptions · $85,108 in drug cost · 44 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 24 | $17,003 | $708 |
| Sod Sulf-Potass Sulf-Mag Sulf | 130 | $7,905 | $61 |
| Tetracycline | 16 | $3,095 | $193 |
| Hydrocortisone | 16 | $556 | $35 |
| Omeprazole | 79 | $397 | $5 |
See all 11 drugs
| Linzess | 24 | $17,003 | $708 |
| Sod Sulf-Potass Sulf-Mag Sulf | 130 | $7,905 | $61 |
| Tetracycline | 16 | $3,095 | $193 |
| Hydrocortisone | 16 | $556 | $35 |
| Omeprazole | 79 | $397 | $5 |
| Pantoprazole | 63 | $383 | $6 |
| Gavilyte-G | 32 | $358 | $11 |
| Peg-3350 and Electrolytes | 13 | $213 | $16 |
| Dicyclomine | 16 | $209 | $13 |
| Famotidine | 23 | $209 | $9 |
| Metronidazole | 18 | $129 | $7 |
Year by year
| 2024 | 550 | 276 | None | 20% | $85,108 |
| 2023 | 293 | 149 | 0% (0) | 25% | $66,251 |
| 2022 | 193 | 109 | 0% (0) | 38% | $25,827 |
| 2021 | 124 | 63 | 0% (0) | 21% | $54,509 |
| 2020 | 169 | 68 | 0% (0) | 24% | $108,705 |
| 2019 | 197 | 84 | None | 21% | $149,083 |
| 2018 | 329 | 70 | 9% (29) | None | $45,383 |
| 2017 | 238 | 46 | 13% (30) | None | $13,546 |
| 2016 | 251 | 32 | 10% (25) | None | $21,493 |
| 2015 | 93 | None | None | None | $4,652 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Linzess | 16 | $10,276 | $642 |
| Sod Sulf-Potass Sulf-Mag Sulf | 56 | $4,462 | $80 |
| Hydrocortisone | 11 | $927 | $84 |
| Omeprazole | 43 | $749 | $17 |
| Gavilyte-G | 19 | $441 | $23 |
| Famotidine | 13 | $324 | $25 |
| Dicyclomine | 14 | $234 | $17 |
| Pantoprazole | 16 | $215 | $13 |
2022: 4 drugs
| Suprep | 31 | $3,395 | $110 |
| Sod Sulf-Potass Sulf-Mag Sulf | 17 | $1,320 | $78 |
| Omeprazole | 25 | $303 | $12 |
| Pantoprazole | 17 | $225 | $13 |
2021: 2 drugs
| Creon | 14 | $31,022 | $2,216 |
| Omeprazole | 13 | $299 | $23 |
2020: 4 drugs
| Mercaptopurine | 15 | $788 | $53 |
| Omeprazole | 30 | $690 | $23 |
| Dicyclomine | 13 | $422 | $32 |
| Gavilyte-G | 11 | $160 | $15 |
2019: 4 drugs
| Omeprazole | 29 | $517 | $18 |
| Gavilyte-G | 22 | $346 | $16 |
| Pantoprazole | 13 | $209 | $16 |
| Dicyclomine | 16 | $195 | $12 |
2018: 11 drugs
| Lyrica | 12 | $8,124 | $677 |
| Hydrocodone-Acetaminophen | 15 | $266 | $18 |
| Levothyroxine | 13 | $250 | $19 |
| Gavilyte-G | 14 | $219 | $16 |
| Fluticasone Propionate | 15 | $217 | $14 |
| Gabapentin | 11 | $210 | $19 |
| Amlodipine Besylate | 19 | $119 | $6 |
| Losartan | 13 | $93 | $7 |
| Lisinopril | 11 | $93 | $8 |
| Atorvastatin | 12 | $92 | $8 |
| Carvedilol | 13 | $71 | $5 |
2017: 4 drugs
| Gabapentin | 21 | $758 | $36 |
| Levothyroxine | 13 | $264 | $20 |
| Atorvastatin | 17 | $242 | $14 |
| Hydrocodone-Acetaminophen | 11 | $183 | $17 |
2016: 5 drugs
| Gabapentin | 11 | $333 | $30 |
| Hydrocodone-Acetaminophen | 11 | $315 | $29 |
| Amlodipine Besylate | 23 | $110 | $5 |
| Simvastatin | 15 | $99 | $7 |
| Trazodone | 11 | $44 | $4 |
Money from drug and device companies
$1,984 in 2025
| 2025 | 10 | 13 | None | $1,984 |
| 2024 | 5 | 6 | None | $106 |
| 2023 | 3 | 10 | None | $1,007 |
| 2022 | 7 | 19 | None | $1,733 |
| 2021 | 4 | 9 | None | $1,070 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ovesco Endoscopy USA | None | $783 | 1 payment
|
| Boston Scientific | Overstitch Endoscopic Suturing System | $695 | 3 payments
|
| 3-D Matrix | None | $321 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $40 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $33 | 1 payment
|
| Phathom Pharmaceuticals | Voquezna | $30 | 1 payment
|
See all 12 published payments
| Ovesco Endoscopy USA | Travel · 2025-11-21 | None | $783 |
| Erbe USA | Meals · 2025-10-04 | Vio3, Apc3, Hapc | $20 |
| Janssen Biotech | Meals · 2025-10-01 | Tremfya | $22 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-09-24 | Entyvio | $40 |
| Braintree Laboratories | Meals · 2025-09-03 | Suflave | $21 |
| Boston Scientific | Meals · 2025-04-25 | Overstitch Endoscopic Suturing System | $75 |
| Boston Scientific | Travel · 2025-04-24 | Overstitch Endoscopic Suturing System | $245 |
| Boston Scientific | Travel · 2025-04-24 | Overstitch Endoscopic Suturing System | $375 |
| Phathom Pharmaceuticals | Meals · 2025-04-16 | Voquezna | $30 |
| Madrigal Pharmaceuticals | Meals · 2025-04-02 | Rezdiffra | $33 |
| 3-D Matrix | Meals · 2025-04-01 | None | $321 |
| Gilead Sciences | Meals · 2025-03-12 | None | $19 |
See earlier years (2024, 2023, 2022, 2021)
2024: $106
| Abbvie | Linzess | $36 | 2 payments
|
| Olympus America | Endoclot Phs | $24 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $21 | 1 payment
|
| Braintree Laboratories | Suflave | $14 | 1 payment
|
| Micro-tech Endoscopy USA | Eyemx | $12 | 1 payment
|
2023: $1,007
| Olympus Corporation of the Americas | Single Use Electrosurgical Knife Kd-655 | $912 | 8 payments
|
| Gilead Sciences | None | $80 | 1 payment
|
| Olympus America | Endoclot Phs | $16 | 1 payment
|
2022: $1,733
| Boston Scientific | General - Therapies | $1,035 | 12 payments
|
| Gilead Sciences | Vemlidy | $243 | 2 payments
|
| Conmed | Conmed Biliary | $143 | 1 payment
|
| Medtronic | Gi Genius | $107 | 1 payment
|
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $103 | 1 payment
|
| Merit Medical Systems | Alimaxx-Es Stent/Del Sys | $81 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $23 | 1 payment
|
2021: $1,070
| Boston Scientific | General - Therapies | $771 | 6 payments
|
| Medtronic | Endoflip | $124 | 1 payment
|
| Endogastric Solutions | Esophyx | $101 | 1 payment
|
| Olympus Corporation of the Americas | Single Use Biliary Stent V | $74 | 1 payment
|
Professional record
- NPI
- 1073900163
- Licence
- NM A-2504-21
- Trained
- Arizona College of Osteopathic Medicine Mid Western University, 2015
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2331 Montpelier Dr Ste B, San Jose, CA, 95116
- NPI first listed
- 2015-04-16
- NPI last updated
- 2022-05-19
- NPI record certified
- 2022-05-19
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 231 Oconnor Dr, San Jose, CA, 95128